成都市高新区交子大道 333 号中海国际中心 E 座 602 室 电话：028-65585333 传真：028-66266533 邮编：610041 北京国枫（成都）律师事务所 关于成都华神科技集团股份有限公司 2025 年第一次临时股东大会的 法律意见书 国枫律股字[2025]D0018 号 致：成都华神科技集团股份有限公司（贵公司） 北京国枫（成都）律师事务所（以下简称"本所"）接受贵公司的委托，指派律师出 席并见证贵公司 2025 年第一次临时股东大会（以下简称"本次会议"）。 本所律师根据《中华人民共和国公司法》（以下简称"《公司法》"）、《中华人民 共和国证券法》（以下简称"《证券法》"）、《上市公司股东会规则》（以下简称"《股 东会规则》"）、《律师事务所从事证券法律业务管理办法》（以下简称"《证券法律业 务管理办法》"）、《律师事务所证券法律业务执业规则（试行）》（以下简称"《证券 法律业务执业规则》"）等相关法律、行政法规、规章、规范性文件及《成都华神科技 集团股份有限公司章程》（以下简称"《公司章程》"）的规定，就本次会议的召集与召 开程序、召集人资格、出席会议人员资格、会议表决程序及表决结 ...

Group 1 - The company emphasizes the importance of intellectual property protection in its production and operation processes [1] - The company commits to timely application for relevant patents [1]

Core Viewpoint - The company is actively expanding its sales channels, particularly in the e-commerce and OTC markets, to enhance brand presence and market coverage [1] Group 1 - The company has confirmed that some of its products are being sold through mainstream e-commerce channels [1] - The company is focusing on expanding its presence in the outpatient market [1] - The company plans to strengthen the development of new marketing channels, especially through new media marketing [1]

Core Viewpoint - The company Huasheng Technology (000790) emphasizes the significance of its core traditional Chinese medicine product, Sanqi Tongshu Capsule, which is recognized as a national secondary protected variety of traditional Chinese medicine [1] Company Summary - Sanqi Tongshu Capsule is derived from the active components of Sanqi herb, specifically the effective part known as Sanqi saponins, which is used for its properties in promoting blood circulation and resolving blood stasis [1] - The product is classified as a new generation Sanqi formulation, with a clear material basis, defined active ingredients, and a well-understood mechanism of action [1] - Sanqi Tongshu Capsule has multiple therapeutic effects, including anti-platelet aggregation, prevention of thrombosis, improvement of cerebral ischemia, and promotion of neurological function recovery [1] - The product has evolved into a major traditional Chinese medicine for treating cardiovascular and cerebrovascular diseases [1]

证券日报网讯华神科技（000790）8月12日在互动平台回答投资者提问时表示，公司子公司华神生物公 司拥有国家一类新药利卡汀(碘[131I]美妥昔单抗注射液)产品，主要用于不能手术切除或术后复发的原 发性肝癌，以及不适宜作动脉导管化学栓塞(TACE)或经TACE治疗后无效、复发的晚期肝癌患者。 ...

证券日报网讯华神科技（000790）8月12日在互动平台回答投资者提问时表示，目前公司子公司华神钢 构暂未参与西藏扎曲果多水电站建设项目。 ...

Core Viewpoint - Huasheng Technology (000790) emphasizes the prescription nature of its product, Sanqi Tongshu Capsule, and acknowledges the need for improved channel layout and refined operations in specific markets [1] Group 1: Market Strategy - The company plans to enhance market expansion efforts and improve product accessibility in key cities across the country [1] - Ongoing initiatives include strengthening supply chain collaboration and optimizing resource allocation dynamically [1] Group 2: Operational Focus - The company recognizes the potential for improvement in channel management and operational efficiency [1] - Continuous efforts are being made to refine channel management practices [1]

证券日报网讯华神科技（000790）8月12日在互动平台回答投资者提问时表示，公司子公司海南华神星 瑞药业科技有限公司作为公司医药大健康产业布局的组成部分，公司将持续深耕医药大健康产业。 ...

每经AI快讯，有投资者在投资者互动平台提问：公司是否有护牙的漱口瓶装水卖吗？ 华神科技（000790.SZ）8月12日在投资者互动平台表示，公司暂无上述产品。 （文章来源：每日经济新闻） ...

每经AI快讯，有投资者在投资者互动平台提问：公司子公司成都华神生物技术有限责任公司生产的国 家一类新药——碘[131I>美妥昔单抗注射液（利卡汀）是公司自研的吗？主要针对那些疾病？ 华神科技（000790.SZ）8月12日在投资者互动平台表示，公司子公司华神生物公司拥有国家一类新药利 卡汀（碘[131I]美妥昔单抗注射液）产品，主要用于不能手术切除或术后复发的原发性肝癌，以及不适 宜作动脉导管化学栓塞（TACE）或经TACE治疗后无效、复发的晚期肝癌患者。 （文章来源：每日经济新闻） ...